0B68 Anne, Rani P. - Thomas Jefferson University - Thomas Jefferson University
pra101

Rani P. Anne, MD

Contact Dr. Anne

111 South 11th Street
Room G-301, Bodine Center
Philadelphia, PA 19107

(215) 955-6702
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib 21C1 With Concurrent Radiotherapy for Advanced Head and Neck Cancer
  2. Eastern cooperative oncology group and american college of radiology imaging network randomized phase 2 trial of neoadjuvant preoperative paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial Design
  3. Yttrium-90 microsphere brachytherapy for liver metastases from uveal melanoma clinical outcomes and the predictive value of fluorodeoxyglucose positron emission tomography
  4. Modeled risk of ischemic heart disease following left breast irradiation with deep inspiration breath hold
  5. Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial
  6. NRG oncology radiation therapy oncology group 0822: A phase 2 study of preoperative chemoradiation therapy using intensity modulated radiation therapy in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancer
  7. Efficacy endpoints of radiation therapy group protocol 0247: A randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer
  8. Conditional survival probabilities for patients with resected pancreatic adenocarcinoma
  9. Radiation therapy use and outcomes among older women with ER-Positive and ER-negative stage I breast cancer
  10. Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer
  11. Impact of a radiation oncology elective on the careers of young physicians: Update on a prospective cohort study
  12. Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer
  13. Head and neck carcinoma in the United States: First comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)
  14. Implementation and experimental results of 4D tumor tracking using robotic couch
  15. Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies
  16. Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school
  17. Radiation therapy in breast-conserving therapy for invasive breast cancer
  18. Radiation therapy oncology group 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer
  19. Toxicities after radioembolization with yttrium-90 SIR-spheres: Incidence and contributing risk factors at a single center
  20. The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma
0